Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Cancer and Metastasis Reviews

Issue 3/1999

Content (6 Articles)

Melanoma Cell Autonomous Growth: The Rb/E2F Pathway

Ruth Halaban

Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma

Judith P. Johnson

Molecular Role(s) for Integrins in Human Melanoma Invasion

Richard E.B. Seftor, Elisabeth A. Seftor, Mary J.C. Hendrix

Role of AP-2 in Tumor Growth and Metastasis of Human Melanoma

Menashe Bar-Eli

The Biology of Melanoma Brain Metastasis

Isaiah J. Fidler, Gabriele Schackert, Ruo-dan Zhang, Robert Radinsky, Takamitsu Fujimaki

Human Xenografts, Human Skin and Skin Reconstructs for Studies in Melanoma Development and Progression

Kapaettu Satyamoorthy, Friedegund Meier, Mei-Yu Hsu, Carola Berking, Meenhard Herlyn

May 99
Issue: 2/1999
Dec 99
Issue: 4/1999

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits